235 related articles for article (PubMed ID: 20433605)
1. A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy.
Viala K; Maisonobe T; Stojkovic T; Koutlidis R; Ayrignac X; Musset L; Fournier E; Léger JM; Bouche P
J Peripher Nerv Syst; 2010 Mar; 15(1):50-6. PubMed ID: 20433605
[TBL] [Abstract][Full Text] [Related]
2. Fatigue as the main presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy: a study of 11 cases.
Boukhris S; Magy L; Gallouedec G; Khalil M; Couratier P; Gil J; Vallat JM
J Peripher Nerv Syst; 2005 Sep; 10(3):329-37. PubMed ID: 16221292
[TBL] [Abstract][Full Text] [Related]
3. Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy.
Tackenberg B; Lünemann JD; Steinbrecher A; Rothenfusser-Korber E; Sailer M; Brück W; Schock S; Zschenderlein R; Zipp F; Sommer N
Neurology; 2007 May; 68(19):1622-9. PubMed ID: 17485651
[TBL] [Abstract][Full Text] [Related]
4. Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP.
Abraham A; Breiner A; Katzberg HD; Lovblom LE; Perkins BA; Bril V
Expert Rev Clin Immunol; 2015 Apr; 11(4):537-46. PubMed ID: 25764107
[TBL] [Abstract][Full Text] [Related]
5. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
Joint Task Force of the EFNS and the PNS
J Peripher Nerv Syst; 2005 Sep; 10(3):220-8. PubMed ID: 16221283
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of intravenous immunoglobulin in CIDP.
Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
[TBL] [Abstract][Full Text] [Related]
7. Segmental evaluation of the peripheral nerve using tibial nerve SEPs for the diagnosis of CIDP.
Tsukamoto H; Sonoo M; Shimizu T
Clin Neurophysiol; 2010 Jan; 121(1):77-84. PubMed ID: 19850515
[TBL] [Abstract][Full Text] [Related]
8. [Importance of the nerve biopsy for the diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuritis: 8 cases].
Vallat JM; Tabaraud F; Magy L; Couratier P
Bull Acad Natl Med; 2003; 187(2):387-99; discussion 399-403. PubMed ID: 14556448
[TBL] [Abstract][Full Text] [Related]
9. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
Jann S; Beretta S; Bramerio MA
Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
[TBL] [Abstract][Full Text] [Related]
10. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.
Magda P; Latov N; Brannagan TH; Weimer LH; Chin RL; Sander HW
Arch Neurol; 2003 Dec; 60(12):1755-9. PubMed ID: 14676052
[TBL] [Abstract][Full Text] [Related]
11. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
Wadwekar V; Kalita J; Misra UK
Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
[TBL] [Abstract][Full Text] [Related]
12. Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria?
Liberatore G; Manganelli F; Doneddu PE; Cocito D; Fazio R; Briani C; Filosto M; Benedetti L; Mazzeo A; Antonini G; Cosentino G; Jann S; Cortese A; Marfia GA; Clerici AM; Siciliano G; Carpo M; Luigetti M; Lauria G; Rosso T; Cavaletti G; Santoro L; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Schenone A; Leonardi L; Toscano A; Mataluni G; Spina E; Gentile L; Nobile-Orazio E;
Eur J Neurol; 2021 Feb; 28(2):620-629. PubMed ID: 32959475
[TBL] [Abstract][Full Text] [Related]
13. The treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Kissel JT
Semin Neurol; 2003 Jun; 23(2):169-80. PubMed ID: 12894382
[TBL] [Abstract][Full Text] [Related]
14. Pain as the presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Boukhris S; Magy L; Khalil M; Sindou P; Vallat JM
J Neurol Sci; 2007 Mar; 254(1-2):33-8. PubMed ID: 17286985
[TBL] [Abstract][Full Text] [Related]
15. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
[TBL] [Abstract][Full Text] [Related]
16. Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.
Sharma KR; Saadia D; Facca AG; Bhatia R; Ayyar DR; Sheremata W
J Clin Neuromuscul Dis; 2008 Jun; 9(4):385-96. PubMed ID: 18525422
[TBL] [Abstract][Full Text] [Related]
17. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
Vina ER; Fang AJ; Wallace DJ; Weisman MH
Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
[TBL] [Abstract][Full Text] [Related]
18. CIDP diagnostic pitfalls and perception of treatment benefit.
Allen JA; Lewis RA
Neurology; 2015 Aug; 85(6):498-504. PubMed ID: 26180143
[TBL] [Abstract][Full Text] [Related]
19. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
Haq RU; Pendlebury WW; Fries TJ; Tandan R
Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
Lopate G; Pestronk A; Al-Lozi M
Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
